Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Breast Cancer 2024

Satellite Symposia Webcasts

ESMO-Breast-Cancer-2024-1000x250

Slides and webcasts from the Satellite Symposia Webcasts are now available here to ESMO members. The use of these slides is for personal educational purposes only. ESMO thanks the authors for their generosity

Hide
Filter by:
Search:
Reset

There are 16 resources available

Welcome and introduction

Presenter: Wolfgang Janni

Session: Novartis - Breaking new ground with CDK4/6 inhibitors: Case-based discussions on treatment decisions in HR+/HER2- breast cancer

Resources:

Webcast

Unmet need in HR+/HER2- early breast cancer

Presenter: Wolfgang Janni

Session: Novartis - Breaking new ground with CDK4/6 inhibitors: Case-based discussions on treatment decisions in HR+/HER2- breast cancer

Resources:

Webcast

Closing and key takeaways

Presenter: Wolfgang Janni

Session: Novartis - Breaking new ground with CDK4/6 inhibitors: Case-based discussions on treatment decisions in HR+/HER2- breast cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.